Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer. Arch Ital Urol Androl. 2016;88(1):72-73. doi:10.4081/aiua.2016.1.72